Literature DB >> 31597206

The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.

Maki Tobari1, Etsuko Hashimoto2, Makiko Taniai2, Kazuhisa Kodama2, Tomomi Kogiso2, Katsutoshi Tokushige2, Masakazu Yamamoto3, Nishino Takayoshi1, Katagiri Satoshi4, Araida Tatsuo4.   

Abstract

BACKGROUND AND AIM: We evaluated the characteristics of hepatocellular carcinoma (HCC) in patients who had non-alcoholic fatty liver disease (NAFLD) without cirrhosis.
METHODS: We prospectively followed NAFLD patients at our University hospital. NAFLD was diagnosed from detection of steatosis by histology or imaging, no alcohol intake, and exclusion of other liver diseases. Cirrhosis was defined by histological features, imaging data, and symptoms. We compared NAFLD-related HCC with or without cirrhosis and non-cirrhotic NAFLD with or without HCC.
RESULTS: There were 48 non-cirrhotic HCC patients and 71 cirrhotic HCC patients. Multiple logistic regression analysis revealed that other than liver function factors, male gender (OR: 5.603, 95%CI: 1.577-19.900), light drinker (OR: 2.797, 95%CI: 1.031-7.589), and tumor size (OR: 1.031, 95%CI 1.009-1.055) differ significantly between these two groups. The recurrence rate was significantly lower in the non-cirrhotic HCC group than the cirrhotic HCC group, with risk factors being des-γ-carboxy prothrombin and the number of HCCs. The non-cirrhotic HCC group showed significantly better survival because of absence of non-cancerous liver failure. Comparison between non-cirrhotic NAFLD patients with or without HCC (n = 612) revealed the following risk factors for HCC: male gender (OR: 7.774, 95%CI: 2.176-27.775), light drinker (OR: 4.893, 95%CI: 1.923-12.449), and high FIB4 index (OR 2.634, 95%CI: 1.787-3.884).
CONCLUSION: In patients with non-cirrhotic NAFLD, important risk factors for HCC were male gender, alcohol consumption, and the FIB4 index. HCC recurrence and survival were only influenced by the tumor stage. We should be aware of alcohol consumption as a modifiable risk factor for HCC.
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  AFLD; HCC; HCC in non-cirrhosis; NASH; alcohol consumption; non-cirrhotic NAFLD; risk factors for HCC

Year:  2019        PMID: 31597206     DOI: 10.1111/jgh.14867

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Diabetes and hepatocellular carcinoma risks in patients with nonalcoholic steatohepatitis related cirrhosis.

Authors:  Chien-Hsieh Chiang; Kuo-Chin Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

Review 2.  Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma.

Authors:  Norberto C Chavez-Tapia; Sofía Murúa-Beltrán Gall; Ana Luisa Ordoñez-Vázquez; Natalia Nuño-Lambarri; Paulina Vidal-Cevallos; Misael Uribe
Journal:  J Hepatocell Carcinoma       Date:  2022-07-05

3.  Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study.

Authors:  Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Linh Pham Van; Hung Nguyen Van; Hoi Nguyen Thanh
Journal:  Biomed Res Int       Date:  2022-05-06       Impact factor: 3.246

4.  FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance?

Authors:  Antonio Saviano; Simona Tripon; Thomas F Baumert
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 8.265

5.  Genomic Landscape of HCC.

Authors:  Adeniji Nia; Renumathy Dhanasekaran
Journal:  Curr Hepatol Rep       Date:  2020-11-10

Review 6.  Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.

Authors:  Amedeo Lonardo; Ayako Suzuki
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 7.  The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

Review 8.  Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements.

Authors:  Abhilash Perisetti; Hemant Goyal; Rachana Yendala; Ragesh B Thandassery; Emmanouil Giorgakis
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

9.  Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis.

Authors:  Adrian T Billeter; Philip C Müller; Thomas Albrecht; Stephanie Roessler; Moritz Löffler; Anastasia Lemekhova; Arianeb Mehrabi; Beat P Müller-Stich; Katrin Hoffmann
Journal:  J Gastrointest Surg       Date:  2020-05-06       Impact factor: 3.452

10.  Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.

Authors:  Archita P Desai; Marion Greene; Lauren D Nephew; Eric S Orman; Marwan Ghabril; Naga Chalasani; Nir Menachemi
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.